Parthenon Therapeutics
BioTech/Drugs - Cambridge, MA, US
Parthenon Therapeutics Employees
Parthenon Therapeutics Senior Management
Parthenon Therapeutics Details
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on rigorous, groundbreaking research, we are designing a portfolio of drug candidates to treat the right patients at the right time.
Website:
parthenontx.com
Employees:
20 - 49
HQ:
N/A
Location:
Cambridge, MA, US
Revenue:
2.5 - 5 Million
Parthenon Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WordPress.org
Fonts
Google Font API
Analytics and Tracking
Google Analytics
Other
Mobile Friendly